Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Exchange Rate Effect (2016 - 2025)

Dexcom (DXCM) has disclosed Exchange Rate Effect for 13 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 133.93% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.5 million, a 390.54% increase, with the full-year FY2025 number at $21.5 million, up 390.54% from a year prior.
  • Exchange Rate Effect was $3.8 million for Q4 2025 at Dexcom, up from -$1.1 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $16.5 million in Q2 2025 to a low of -$11.2 million in Q4 2024.
  • A 5-year average of $420000.0 and a median of -$750000.0 in 2021 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: tumbled 960.0% in 2022, then skyrocketed 1750.0% in 2025.
  • Dexcom's Exchange Rate Effect stood at -$500000.0 in 2021, then soared by 1460.0% to $6.8 million in 2022, then decreased by 10.29% to $6.1 million in 2023, then tumbled by 283.61% to -$11.2 million in 2024, then skyrocketed by 133.93% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Exchange Rate Effect are $3.8 million (Q4 2025), -$1.1 million (Q3 2025), and $16.5 million (Q2 2025).